Page last updated: 2024-09-02

arginyl-glycyl-aspartyl-serine and Neonatal Alloimmune Thrombocytopenia

arginyl-glycyl-aspartyl-serine has been researched along with Neonatal Alloimmune Thrombocytopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dusseaux, M; Jallu, V; Kaplan, C1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Neonatal Alloimmune Thrombocytopenia

ArticleYear
A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia.
    Transfusion, 2011, Volume: 51, Issue:2

    Topics: Adult; Amino Acid Substitution; Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Cricetulus; Diseases in Twins; Epitopes; Female; Fibrinogen; Heterozygote; Humans; Immunity, Maternally-Acquired; Infant, Newborn; Integrin beta3; Male; Oligopeptides; Platelet Adhesiveness; Platelet Membrane Glycoprotein IIb; Polymorphism, Single Nucleotide; Protein Interaction Mapping; Structure-Activity Relationship; Thrombocytopenia, Neonatal Alloimmune; Transfection

2011